Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Calculus Capital (Funds)
Calculus VCT Fund
By
Dr Brian Moretta
18 Feb 2019
Calculus Capital (Funds)
Financials
Calculus EIS Fund
By
Dr Brian Moretta
07 Feb 2019
Chamberlin Plc
Industrial
Trading very difficult; forecasts lowered
By
Paul Singer
06 Feb 2019
Avacta Group plc
Life Sciences
A second wake-up call for the market
06 Feb 2019
The Monthly: February 2019
05 Feb 2019
Shield Therapeutics Plc
Life Sciences
Cast-iron investment
By
Dr Martin Hall
28 Jan 2019
AJ Bell
Financials
Platform for growth
By
Jason Streets
24 Jan 2019
City of London Investment Group
Financials
Solid FUM update offset by margin changes
By
Dr Brian Moretta
21 Jan 2019
Advanced Oncotherapy
Life Sciences
Important regulatory milestone: ISO approval
21 Jan 2019
Allergy Therapeutics plc
Life Sciences
Trading update: gaining market share
17 Jan 2019
1pm Plc
Financials
Interim results 1H FY’19: geared up for growth
By
Mark Thomas
16 Jan 2019
Prev
1
...
61
62
63
64
65
...
84
Next
